| 86R717 KFF-D  
---|---  
|  By: Shaheen | H.B. No. 437  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to allowing Medicaid managed care organizations to adopt  
| their own drug formularies.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Section 531.072(a), Government Code, is amended  
| to read as follows:  
|  (a) In a manner that complies with applicable state and  
| federal law, the commission shall adopt preferred drug lists for  
| the Medicaid vendor drug program and for prescription drugs  
| purchased through the child health plan program. _Except as_  
| _provided by Section 531.0721, the_ [ ~~The~~ ] commission may adopt  
| preferred drug lists for community mental health centers, state  
| mental health hospitals, and any other state program administered  
| by the commission or a state health and human services agency.  
|  SECTION 2. Subchapter B, Chapter 531, Government Code, is  
| amended by adding Section 531.0721 to read as follows:  
|  _Sec._ ___531.0721._ _____ADOPTION OF PRESCRIPTION DRUG FORMULARY BY_  
| _MEDICAID MANAGED CARE ORGANIZATION. A managed care organization_  
| _providing an outpatient pharmacy benefit plan for its Medicaid_  
| _enrolled recipients may adopt its own drug formulary and is not_  
| _required to:_  
|  _(1) employ the vendor drug program formulary; or_  
|  _(2)_ _____otherwise adhere to a preferred drug list the_  
| _commission adopts under Section 531.072._  
|  SECTION 3. Section 531.073, Government Code, is amended by  
| amending Subsection (a) and adding Subsection (j) to read as  
| follows:  
|  (a) The executive commissioner, in the rules and standards  
| governing the Medicaid vendor drug program and the child health  
| plan program, shall require prior authorization for the  
| reimbursement of a drug that is not included in the appropriate  
| preferred drug list adopted under Section 531.072, except _as_  
| _provided by Subsection (j) and_ for any drug exempted from prior  
| authorization requirements by federal law.  _Except as provided by_  
| _Subsection (j), the_ [ ~~The~~ ] executive commissioner may require prior  
| authorization for the reimbursement of a drug provided through any  
| other state program administered by the commission or a state  
| health and human services agency, including a community mental  
| health center and a state mental health hospital if the commission  
| adopts preferred drug lists under Section 531.072 that apply to  
| those facilities and the drug is not included in the appropriate  
| list.  The executive commissioner shall require that the prior  
| authorization be obtained by the prescribing physician or  
| prescribing practitioner.  
|  _(j)_ _____This section does not apply to a managed care_  
| _organization that elects to adopt its own drug formulary under_  
| _Section 531.0721._  
|  SECTION 4. Sections 533.005(a) and (a-2), Government Code,  
| are amended to read as follows:  
|  (a) A contract between a managed care organization and the  
| commission for the organization to provide health care services to  
| recipients must contain:  
|  (1) procedures to ensure accountability to the state  
| for the provision of health care services, including procedures for  
| financial reporting, quality assurance, utilization review, and  
| assurance of contract and subcontract compliance;  
|  (2) capitation rates that ensure the cost-effective  
| provision of quality health care;  
|  (3) a requirement that the managed care organization  
| provide ready access to a person who assists recipients in  
| resolving issues relating to enrollment, plan administration,  
| education and training, access to services, and grievance  
| procedures;  
|  (4) a requirement that the managed care organization  
| provide ready access to a person who assists providers in resolving  
| issues relating to payment, plan administration, education and  
| training, and grievance procedures;  
|  (5) a requirement that the managed care organization  
| provide information and referral about the availability of  
| educational, social, and other community services that could  
| benefit a recipient;  
|  (6) procedures for recipient outreach and education;  
|  (7) a requirement that the managed care organization  
| make payment to a physician or provider for health care services  
| rendered to a recipient under a managed care plan on any claim for  
| payment that is received with documentation reasonably necessary  
| for the managed care organization to process the claim:  
|  (A) not later than:  
|  (i) the 10th day after the date the claim is  
| received if the claim relates to services provided by a nursing  
| facility, intermediate care facility, or group home;  
|  (ii) the 30th day after the date the claim  
| is received if the claim relates to the provision of long-term  
| services and supports not subject to Subparagraph (i); and  
|  (iii) the 45th day after the date the claim  
| is received if the claim is not subject to Subparagraph (i) or (ii);  
| or  
|  (B) within a period, not to exceed 60 days,  
| specified by a written agreement between the physician or provider  
| and the managed care organization;  
|  (7-a) a requirement that the managed care organization  
| demonstrate to the commission that the organization pays claims  
| described by Subdivision (7)(A)(ii) on average not later than the  
| 21st day after the date the claim is received by the organization;  
|  (8) a requirement that the commission, on the date of a  
| recipient's enrollment in a managed care plan issued by the managed  
| care organization, inform the organization of the recipient's  
| Medicaid certification date;  
|  (9) a requirement that the managed care organization  
| comply with Section 533.006 as a condition of contract retention  
| and renewal;  
|  (10) a requirement that the managed care organization  
| provide the information required by Section 533.012 and otherwise  
| comply and cooperate with the commission's office of inspector  
| general and the office of the attorney general;  
|  (11) a requirement that the managed care  
| organization's usages of out-of-network providers or groups of  
| out-of-network providers may not exceed limits for those usages  
| relating to total inpatient admissions, total outpatient services,  
| and emergency room admissions determined by the commission;  
|  (12) if the commission finds that a managed care  
| organization has violated Subdivision (11), a requirement that the  
| managed care organization reimburse an out-of-network provider for  
| health care services at a rate that is equal to the allowable rate  
| for those services, as determined under Sections 32.028 and  
| 32.0281, Human Resources Code;  
|  (13) a requirement that, notwithstanding any other  
| law, including Sections 843.312 and 1301.052, Insurance Code, the  
| organization:  
|  (A) use advanced practice registered nurses and  
| physician assistants in addition to physicians as primary care  
| providers to increase the availability of primary care providers in  
| the organization's provider network; and  
|  (B) treat advanced practice registered nurses  
| and physician assistants in the same manner as primary care  
| physicians with regard to:  
|  (i) selection and assignment as primary  
| care providers;  
|  (ii) inclusion as primary care providers in  
| the organization's provider network; and  
|  (iii) inclusion as primary care providers  
| in any provider network directory maintained by the organization;  
|  (14) a requirement that the managed care organization  
| reimburse a federally qualified health center or rural health  
| clinic for health care services provided to a recipient outside of  
| regular business hours, including on a weekend day or holiday, at a  
| rate that is equal to the allowable rate for those services as  
| determined under Section 32.028, Human Resources Code, if the  
| recipient does not have a referral from the recipient's primary  
| care physician;  
|  (15) a requirement that the managed care organization  
| develop, implement, and maintain a system for tracking and  
| resolving all provider appeals related to claims payment, including  
| a process that will require:  
|  (A) a tracking mechanism to document the status  
| and final disposition of each provider's claims payment appeal;  
|  (B) the contracting with physicians who are not  
| network providers and who are of the same or related specialty as  
| the appealing physician to resolve claims disputes related to  
| denial on the basis of medical necessity that remain unresolved  
| subsequent to a provider appeal;  
|  (C) the determination of the physician resolving  
| the dispute to be binding on the managed care organization and  
| provider; and  
|  (D) the managed care organization to allow a  
| provider with a claim that has not been paid before the time  
| prescribed by Subdivision (7)(A)(ii) to initiate an appeal of that  
| claim;  
|  (16) a requirement that a medical director who is  
| authorized to make medical necessity determinations is available to  
| the region where the managed care organization provides health care  
| services;  
|  (17) a requirement that the managed care organization  
| ensure that a medical director and patient care coordinators and  
| provider and recipient support services personnel are located in  
| the South Texas service region, if the managed care organization  
| provides a managed care plan in that region;  
|  (18) a requirement that the managed care organization  
| provide special programs and materials for recipients with limited  
| English proficiency or low literacy skills;  
|  (19) a requirement that the managed care organization  
| develop and establish a process for responding to provider appeals  
| in the region where the organization provides health care services;  
|  (20) a requirement that the managed care organization:  
|  (A) develop and submit to the commission, before  
| the organization begins to provide health care services to  
| recipients, a comprehensive plan that describes how the  
| organization's provider network complies with the provider access  
| standards established under Section 533.0061;  
|  (B) as a condition of contract retention and  
| renewal:  
|  (i) continue to comply with the provider  
| access standards established under Section 533.0061; and  
|  (ii) make substantial efforts, as  
| determined by the commission, to mitigate or remedy any  
| noncompliance with the provider access standards established under  
| Section 533.0061;  
|  (C) pay liquidated damages for each failure, as  
| determined by the commission, to comply with the provider access  
| standards established under Section 533.0061 in amounts that are  
| reasonably related to the noncompliance; and  
|  (D) regularly, as determined by the commission,  
| submit to the commission and make available to the public a report  
| containing data on the sufficiency of the organization's provider  
| network with regard to providing the care and services described  
| under Section 533.0061(a) and specific data with respect to access  
| to primary care, specialty care, long-term services and supports,  
| nursing services, and therapy services on the average length of  
| time between:  
|  (i) the date a provider requests prior  
| authorization for the care or service and the date the organization  
| approves or denies the request; and  
|  (ii) the date the organization approves a  
| request for prior authorization for the care or service and the date  
| the care or service is initiated;  
|  (21) a requirement that the managed care organization  
| demonstrate to the commission, before the organization begins to  
| provide health care services to recipients, that, subject to the  
| provider access standards established under Section 533.0061:  
|  (A) the organization's provider network has the  
| capacity to serve the number of recipients expected to enroll in a  
| managed care plan offered by the organization;  
|  (B) the organization's provider network  
| includes:  
|  (i) a sufficient number of primary care  
| providers;  
|  (ii) a sufficient variety of provider  
| types;  
|  (iii) a sufficient number of providers of  
| long-term services and supports and specialty pediatric care  
| providers of home and community-based services; and  
|  (iv) providers located throughout the  
| region where the organization will provide health care services;  
| and  
|  (C) health care services will be accessible to  
| recipients through the organization's provider network to a  
| comparable extent that health care services would be available to  
| recipients under a fee-for-service or primary care case management  
| model of Medicaid managed care;  
|  (22) a requirement that the managed care organization  
| develop a monitoring program for measuring the quality of the  
| health care services provided by the organization's provider  
| network that:  
|  (A) incorporates the National Committee for  
| Quality Assurance's Healthcare Effectiveness Data and Information  
| Set (HEDIS) measures;  
|  (B) focuses on measuring outcomes; and  
|  (C) includes the collection and analysis of  
| clinical data relating to prenatal care, preventive care, mental  
| health care, and the treatment of acute and chronic health  
| conditions and substance abuse;  
|  (23) [ ~~subject to Subsection (a-1),~~ ] a requirement that  
| the managed care organization develop, implement, and maintain an  
| outpatient pharmacy benefit plan _and prescription drug formulary_  
| for its enrolled recipients:  
|  (A) [ ~~that exclusively employs the vendor drug~~  
|  ~~program formulary and preserves the state's ability to reduce~~  
|  ~~waste, fraud, and abuse under Medicaid;~~  
|  [ ~~(B)~~ ~~~~ ~~~~ ~~that adheres to the applicable preferred~~  
|  ~~drug list adopted by the commission under Section 531.072;~~  
|  [ ~~(C)~~ ~~~~ ~~~~ ~~that includes the prior authorization~~  
|  ~~procedures and requirements prescribed by or implemented under~~  
|  ~~Sections 531.073(b), (c), and (g) for the vendor drug program;~~  
|  [ ~~(D)~~ ] for purposes of which the managed care  
| organization[ ~~:~~  
|  [ ~~(i)~~ ~~~~ ~~~~ ~~may not negotiate or collect rebates~~  
|  ~~associated with pharmacy products on the vendor drug program~~  
|  ~~formulary; and~~  
|  [ ~~(ii)~~ ] may not receive drug rebate or  
| pricing information that is confidential under Section 531.071;  
|  _(B)_ [ ~~(E)~~ ] that _comply_ [ ~~complies~~ ] with the  
| prohibition under Section 531.089;  
|  _(C)_ [ ~~(F)~~ ] under which the managed care  
| organization may not prohibit, limit, or interfere with a  
| recipient's selection of a pharmacy or pharmacist of the  
| recipient's choice for the provision of pharmaceutical services  
| under the plan through the imposition of different copayments;  
|  _(D)_ [ ~~(G)~~ ] that _allow_ [ ~~allows~~ ] the managed care  
| organization or any subcontracted pharmacy benefit manager to  
| contract with a pharmacist or pharmacy providers separately for  
| specialty pharmacy services, except that:  
|  (i) the managed care organization and  
| pharmacy benefit manager are prohibited from allowing exclusive  
| contracts with a specialty pharmacy owned wholly or partly by the  
| pharmacy benefit manager responsible for the administration of the  
| pharmacy benefit program; and  
|  (ii) the managed care organization and  
| pharmacy benefit manager must adopt policies and procedures for  
| reclassifying prescription drugs from retail to specialty drugs,  
| and those policies and procedures must be consistent with rules  
| adopted by the executive commissioner and include notice to network  
| pharmacy providers from the managed care organization;  
|  _(E)_ [ ~~(H)~~ ] under which the managed care  
| organization may not prevent a pharmacy or pharmacist from  
| participating as a provider if the pharmacy or pharmacist agrees to  
| comply with the financial terms and conditions of the contract as  
| well as other reasonable administrative and professional terms and  
| conditions of the contract;  
|  _(F)_ [ ~~(I)~~ ] under which the managed care  
| organization may include mail-order pharmacies in its networks, but  
| may not require enrolled recipients to use those pharmacies, and  
| may not charge an enrolled recipient who opts to use this service a  
| fee, including postage and handling fees;  
|  _(G)_ [ ~~(J)~~ ] under which the managed care  
| organization or pharmacy benefit manager, as applicable, must pay  
| claims in accordance with Section 843.339, Insurance Code; and  
|  _(H)_ [ ~~(K)~~ ] under which the managed care  
| organization or pharmacy benefit manager, as applicable:  
|  (i) to place a drug on a maximum allowable  
| cost list, must ensure that:  
|  (a) the drug is listed as "A" or "B"  
| rated in the most recent version of the United States Food and Drug  
| Administration's Approved Drug Products with Therapeutic  
| Equivalence Evaluations, also known as the Orange Book, has an "NR"  
| or "NA" rating or a similar rating by a nationally recognized  
| reference; and  
|  (b) the drug is generally available  
| for purchase by pharmacies in the state from national or regional  
| wholesalers and is not obsolete;  
|  (ii) must provide to a network pharmacy  
| provider, at the time a contract is entered into or renewed with the  
| network pharmacy provider, the sources used to determine the  
| maximum allowable cost pricing for the maximum allowable cost list  
| specific to that provider;  
|  (iii) must review and update maximum  
| allowable cost price information at least once every seven days to  
| reflect any modification of maximum allowable cost pricing;  
|  (iv) must, in formulating the maximum  
| allowable cost price for a drug, use only the price of the drug and  
| drugs listed as therapeutically equivalent in the most recent  
| version of the United States Food and Drug Administration's  
| Approved Drug Products with Therapeutic Equivalence Evaluations,  
| also known as the Orange Book;  
|  (v) must establish a process for  
| eliminating products from the maximum allowable cost list or  
| modifying maximum allowable cost prices in a timely manner to  
| remain consistent with pricing changes and product availability in  
| the marketplace;  
|  (vi) must:  
|  (a) provide a procedure under which a  
| network pharmacy provider may challenge a listed maximum allowable  
| cost price for a drug;  
|  (b) respond to a challenge not later  
| than the 15th day after the date the challenge is made;  
|  (c) if the challenge is successful,  
| make an adjustment in the drug price effective on the date the  
| challenge is resolved[ ~~,~~ ] and make the adjustment applicable to all  
| similarly situated network pharmacy providers, as determined by the  
| managed care organization or pharmacy benefit manager, as  
| appropriate;  
|  (d) if the challenge is denied,  
| provide the reason for the denial; and  
|  (e) report to the commission every 90  
| days the total number of challenges that were made and denied in the  
| preceding 90-day period for each maximum allowable cost list drug  
| for which a challenge was denied during the period;  
|  (vii) must notify the commission not later  
| than the 21st day after implementing a practice of using a maximum  
| allowable cost list for drugs dispensed at retail but not by mail;  
| and  
|  (viii) must provide a process for each of  
| its network pharmacy providers to readily access the maximum  
| allowable cost list specific to that provider;  
|  (24) a requirement that the managed care organization  
| and any entity with which the managed care organization contracts  
| for the performance of services under a managed care plan disclose,  
| at no cost, to the commission and, on request, the office of the  
| attorney general all discounts, incentives, rebates, fees, free  
| goods, bundling arrangements, and other agreements affecting the  
| net cost of goods or services provided under the plan;  
|  (25) a requirement that the managed care organization  
| not implement significant, nonnegotiated, across-the-board  
| provider reimbursement rate reductions unless:  
|  (A) subject to Subsection (a-3), the  
| organization has the prior approval of the commission to make the  
| _reductions_ [ ~~reduction~~ ]; or  
|  (B) the rate reductions are based on changes to  
| the Medicaid fee schedule or cost containment initiatives  
| implemented by the commission; and  
|  (26) a requirement that the managed care organization  
| make initial and subsequent primary care provider assignments and  
| changes.  
|  (a-2) Except as provided by Subsection _(a)(23)(H)(viii)_  
| [ ~~(a)(23)(K)(viii)~~ ], a maximum allowable cost list specific to a  
| provider and maintained by a managed care organization or pharmacy  
| benefit manager is confidential.  
|  SECTION 5. Section 533.005(a-1), Government Code, is  
| repealed.  
|  SECTION 6. As soon as practicable after the effective date  
| of this Act, the executive commissioner of the Health and Human  
| Services Commission shall adopt necessary rules to implement the  
| changes in law made by this Act.  
|  SECTION 7. If before implementing any provision of this Act  
| a state agency determines that a waiver or authorization from a  
| federal agency is necessary for implementation of that provision,  
| the agency affected by the provision shall request the waiver or  
| authorization and may delay implementing that provision until the  
| waiver or authorization is granted.  
|  SECTION 8. This Act takes effect September 1, 2019.

